NEW YORK (GenomeWeb News) — The synthetic biology company Verdezyne will develop novel genes for Syngenta, which will test them for enzyme expression in plants, Verdezyne said today.

Formerly called Coda Genomics, Verdezyne uses computational algorithms to design and synthesize gene libraries used to make proteins, metabolic pathways, and microorganisms, which are in turn used to make platform chemicals and biofuels.

Syngenta sells genetically modified plant seeds and biology-based crop protection technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.